ECOG-ACRIN Cancer Research Group

Do you have an aggressive B-cell #Lymphoma that has either come back or persisted after initial therapy? If so, you may be eligible to participate in #ClinicalTrial EA4231. More info here: bit.ly/EA4231 #lymsm

Urothelial cancer is the most common type of #bladdercancer. The EA8192 study is evaluating durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. bit.ly/ea8192-trial cc: @BladderCancerUS @JCensits @PGrivasMDPhD

#ClinicalTrial EA5221/ACHIEVE, led by Dr. Megan Baumgart of @WilmotCancer, aims to help older patients with #LungCancer live longer while also maintaining a good quality of life. Learn more: bit.ly/ea5221-achieve #NSCLC #LCSM

#ClinicalTrial MM1OA-EA02, led by @jaltmanmd of @LurieCancer, aims to improve results for older adults with #AcuteMyeloidLeukemia (#AML). Learn more: bit.ly/mm1oa-ea02-stu…

Do you have newly diagnosed #Glioblastoma? If so, you may be able to participate in this study of a new treatment approach. Learn more about EAF223/GABLE here: bit.ly/gable-trial

Patients with newly diagnosed #MultipleMyeloma may be eligible to participate in #ClinicalTrial EAA181/EQUATE. Learn more here: bit.ly/eaa181equate cc: @myelomaMD, @mtmdphd

#ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump

#ClinicalTrial EA8231, led by @MonikaJoshimd & @PGrivasMDPhD, is a phase 3 randomized study exploring a new treatment approach for patients with treatment-refractory, locally-advanced or metastatic #UrothelialCancer. More information here: bit.ly/ea8231-study

Have you had surgery for squamous cell carcinoma of the head and neck (#HNSCC) that has come back? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/ea3191-study #HeadAndNeckCancer #HNCA

@daehyunleemd @MrinalPatnaik @DrBonnieKy Thank you for attending, we are happy to have you!

#EAOnc is my favorite meeting to attend as a cardiooncologist. During the main symposium, all five speakers mentioned words like atherosclerosis, CV toxicity, CV disease. It shows how intricate the biology of cancer and CVD are connected. Excited for continued collaboration!

Grt ECOG ACRIN MM meeting with many trial concepts presented, brainstormed @eaonc -new ideas -challenges in trial design -accrual challenges - met colleagues and exhchanged grt ideas @VincentRK @myelomaMD @NorthTxMSG @natashaedwin @nsc_natalie @JKaufmanMD @SagarLonialMD

@natashaedwin @JanakiramMurali @VincentRK @myelomaMD @NorthTxMSG @nsc_natalie @JKaufmanMD @SagarLonialMD Thanks for joining us! 🔬

@JanakiramMurali @eaonc @VincentRK @myelomaMD @NorthTxMSG @nsc_natalie @JKaufmanMD @SagarLonialMD Always exciting to learn and have input in designing these excellent and impactful studies. Thanks to @eaonc for organizing this meeting!

@Jani_Chinmay @JackieAredoMD @jillfeldman4 @BenBleibergMD @guicorreiamd Thank you for joining us and sharing your experience! 👏🙌 #EAOnc

@eaonc has been one of the most invigorating meetings to witness how evolving clinical trials continue to refine and improve cancer care. Inspiring discussions, impactful science, and valuable opportunities to meet experts, colleagues, collaborators, and patient advocates all working toward advancing oncology care. @SylvesterCancer @HemOncMiami #Oncology #ClinicalTrials #ECOG #CancerResearch #MedTwitter

Had to get the usual conference picture with @BenBleibergMD 😊 I think this is probably our 7th or 8th conference together over the past 3 years. One of the fun parts of oncology meetings is running into the same colleagues and friends across meetings around the country. @eaonc @SylvesterCancer

@olisaogbue @MrinalPatnaik @AlkaliDr @AntoineNSaliba @tariqkewan @MayoCancerCare @MayoHemeOnc Congratulations! 👏

I’m deeply honored to receive the 2026 #EAOnc Paul Carbone, MD Fellowship Award. Thankful to my mentors at Mayo Clinic for their guidance, encouragement, and investment in my development @MrinalPatnaik @AlkaliDr @AntoineNSaliba @tariqkewan @MayoCancerCare @MayoHemeOnc @eaonc

@KMittalmd 👏👏👏

Love the collaboration with colleagues across multiple committees at @eaonc so many new concepts and exciting ideas!!

Congratulations 🎊 @ValsamoA @HopkinsThoracic for receiving the @eaonc Young Investigator Award for your translational work in understanding ctDNA and lung cancer biology.